The additive to background assumption in cancer risk assessment: A reappraisal

ABSTRACT The assumption that chemical and radiation induced cancers act in a manner that is additive to background was proposed in the mid‐1970s. It was adopted by the U.S. Environmental Protection Agency (EPA) in 1986 and then subsequently by other regulatory agencies worldwide for cancer risk assessment. It ensured that cancer risks at low doses act in a linear fashion. The additive to background process assumes that the mechanism(s) resulting in induced (i.e., treatment related) and spontaneous (i.e., control group) cancers are identical. This assumption could not be properly evaluated due to inadequate mechanistic data when it was proposed in the 1970s. Using the findings of modern molecular toxicology, including oncogene activation/mutation, gene regulation, and molecular pathway analyses, the additive to background assumption was evaluated in the present paper. Based on published studies with 45 carcinogens over 13 diverse mammalian models and for a broad range of tumor types compelling evidence indicates that carcinogen‐induced tumors are mediated in general via mechanisms that are not identical to those affecting the occurrence of the same type of spontaneous tumors in appropriate control groups. These findings, which challenge a fundamental assumption of the additive to background concept, have significant implications for cancer risk assessment policy, regulatory agency practices, as well as fundamental concepts of cancer biology.

[1]  Barbara L Parsons,et al.  Many different tumor types have polyclonal tumor origin: evidence and implications. , 2008, Mutation research.

[2]  L. Dillon.  The Gene , 1987, Springer US.

[3]  Kenneth T Bogen,et al.  Linear‐No‐Threshold Default Assumptions are Unwarranted for Cytotoxic Endpoints Independently Triggered by Ultrasensitive Molecular Switches , 2017, Risk analysis : an official publication of the Society for Risk Analysis.

[4]  Edward J. Calabrese,et al.  The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment , 2009, Archives of Toxicology.

[5]  Elizabeth L. Anderson,et al.  Quantitative Approaches in Use to Assess Cancer Risk , 1983 .

[6]  Marshall W. Anderson,et al.  Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. , 1991, Carcinogenesis.

[7]  L. Stadler,et al.  The Effect of X-Rays upon Mutation of the Gene A in Maize. , 1948, Genetics.

[8]  E. Campo,et al.  Ki‐ras gene mutations and absence of p53 gene mutations in spontaneous and urethane‐induced early lung lesions in CBA/J mice , 1998, Molecular carcinogenesis.

[9]  J Van Ryzin,et al.  Quantitative risk assessment. , 1980, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[10]  R. Melnick,et al.  High frequency of codon 61 K-ras A-->T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene. , 1999, Carcinogenesis.

[11]  D. Iizuka,et al.  DNA Copy Number Aberrations and Disruption of the p16Ink4a/Rb Pathway in Radiation-Induced and Spontaneous Rat Mammary Carcinomas , 2010, Radiation research.

[12]  J A Wiltse,et al.  U.S. Environmental Protection Agency's revised guidelines for carcinogen risk assessment: evaluating a postulated mode of carcinogenic action in guiding dose-response extrapolation. , 2000, Mutation research.

[13]  G. Parmigiani,et al.  A multidimensional analysis of genes mutated in breast and colorectal cancers. , 2007, Genome research.

[14]  M. You,et al.  Ki‐ras mutations in 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone—initiated and butylated hydroxytoluene—promoted lung tumors in A/J mice , 1994, Molecular carcinogenesis.

[15]  D P Lovell,et al.  Quantitative risk assessment and the limitations of the linearized multistage model , 1996, Human & experimental toxicology.

[16]  Hoel Dg.  Incorporation of background in dose-response models. , 1980 .

[17]  Melvin E Andersen,et al.  Linear low-dose extrapolation for noncancer health effects is the exception, not the rule , 2011, Critical reviews in toxicology.

[18]  T. Ushijima,et al.  Gene expression profiling distinguishes between spontaneous and radiation-induced rat mammary carcinomas. , 2008, Journal of radiation research.

[19]  D. Warshawsky,et al.  Carcinogenicity, DNA adduct formation and K-ras activation by 7H-dibenzo[c,g]carbazole in strain A/J mouse lung. , 1996, Carcinogenesis.

[20]  H. Guess,et al.  Uncertainty estimates for low-dose-rate extrapolations of animal carcinogenicity data. , 1977, Cancer research.

[21]  T. Devereux,et al.  Predominant K-ras Codon 12 G → A Transition in Chemically Induced Lung Neoplasms in B6C3F1 Mice , 2004, Toxicologic pathology.

[22]  D. Gaylor.  Some current procedures and issues in cancer risk assessment , 1997 .

[23]  Evans Pa.  Smoking and health. Summary of a report of the Royal College of Physicians of London on smoking in relation to cancer of the lung and other diseases. , 1962 .

[24]  F. Schneider,et al.  Oncogenes and tumor suppressor genes in murine tumors induced by neutron- or gamma-irradiation in utero , 2002 .

[25]  Martin A. Nowak,et al.  Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.

[26]  K S Crump,et al.  A new method for determining allowable daily intakes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[27]  James D. Wilson.  Thresholds for Carcinogens: A Review of the Relevant Science and It's Implications for Regulatory Policy , 1996 .

[28]  P. Armitage,et al.  A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer , 1957, British Journal of Cancer.

[29]  E. Calabrese.  On the origins of the linear no-threshold (LNT) dogma by means of untruths, artful dodges and blind faith. , 2015, Environmental research.

[30]  Mantel Nathan,et al.  Safety" testing of carcinogenic agents. , 1961 .

[31]  A. Greenwell,et al.  Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months. , 1995, Carcinogenesis.

[32]  J. Schwartz,et al.  Multiplex polymerase chain reaction-based deletion analysis of spontaneous, gamma ray- and alpha-induced hprt mutants of CHO-K1 cells. , 1994, Mutagenesis.

[33]  S. Amin,et al.  Comparative mouse skin tumorigenicity and induction of Ha-ras mutations by bay region diol epoxides of 5-methylchrysene and 5,6-dimethylchrysene. , 1998, Carcinogenesis.

[34]  S. Molloi,et al.  Neoplastic Transformation In Vitro after Exposure to Low Doses of Mammographic-Energy X Rays: Quantitative and Mechanistic Aspects , 2004, Radiation research.

[35]  Richard D. Thomas.  Drinking Water and Health , 1986 .

[36]  Shyamal D Peddada,et al.  Genetic alterations in cancer knowledge system: analysis of gene mutations in mouse and human liver and lung tumors. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  N Mantel,et al.  Fundamental carcinogenic processes and their implications for low-dose risk assessment. , 1978, Cancer research.

[38]  T. Cooper.  Department of Health, Education, and Welfare. , 1976, Military medicine.

[39]  Yong Liu,et al.  Analysis of spontaneous, gamma ray- and ethylnitrosourea-induced hprt mutants in HL-60 cells with multiplex PCR. , 2003, World journal of gastroenterology.

[40]  J. Redpath,et al.  Radiation-Induced Neoplastic Transformation in vitro, Hormesis and Risk Assessment , 2007, Dose-response : a publication of International Hormesis Society.

[41]  R. Owen.  Anecdotal, historical and critical commentaries on genetics. , 1989, Genetics.

[42]  R. Prayson,et al.  Mutational Heterogeneity in Human Cancers : Origin and Consequences , 2010 .

[43]  S. Wakana,et al.  Low frequency of Ras gene mutation in spontaneous and gamma-ray-induced thymic lymphomas of scid mice. , 1999, Radiation Research.

[44]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[45]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[46]  Gary L. Gallia,et al.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal , 2013, Proceedings of the National Academy of Sciences.

[47]  R. Maronpot,et al.  ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice. , 1994, Carcinogenesis.

[48]  P. Evans.  Smoking and health. Summary of a report of the Royal College of Physicians of London on smoking in relation to cancer of the lung and other diseases. , 1962, The Central African journal of medicine.

[49]  Terje Aven.  Quantitative risk assessment , 2016 .

[50]  R. Sills,et al.  Genetic Alterations in K-ras and p53 Cancer Genes in Lung Neoplasms from B6C3F1 Mice Exposed to Cumene , 2007, Toxicologic pathology.

[51]  S. Nesnow,et al.  Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice. , 1995, Toxicology.

[52]  R. Wilson,et al.  Evacuation Criteria after a Nuclear Accident: A Personal Perspective , 2012, Dose-response : a publication of International Hormesis Society.

[53]  K. Witt,et al.  Kras, Egfr, and Tp53 Mutations in B6C3F1/N Mouse and F344/NTac Rat Alveolar/Bronchiolar Carcinomas Resulting from Chronic Inhalation Exposure to Cobalt Metal , 2015, Toxicologic pathology.

[54]  T. Devereux,et al.  Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. , 2003, Toxicology and applied pharmacology.

[55]  R. Albert,et al.  Rationale developed by the Environmental Protection Agency for the assessment of carcinogenic risks. , 1977, Journal of the National Cancer Institute.

[56]  Edward J. Calabrese,et al.  Origin of the linearity no threshold (LNT) dose–response concept , 2013, Archives of Toxicology.

[57]  J. Huff,et al.  High Frequency of Ras Mutations in Forestomach and Lung Tumors of B6C3F1 Mice Exposed to 1-Amino-2,4-dibromoanthraquinone for 2 Years , 2001, Toxicologic pathology.

[58]  M. Hegi,et al.  Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator. , 1993, Carcinogenesis.

[59]  J. Shuga,et al.  Integrated Molecular Analysis Indicates Undetectable Change in DNA Damage in Mice after Continuous Irradiation at ~ 400-fold Natural Background Radiation , 2012, Environmental health perspectives.

[60]  W. S. Abbott,et al.  A method of computing the effectiveness of an insecticide. 1925. , 1925, Journal of the American Mosquito Control Association.

[61]  H. Roman.  A diamond in a desert. , 1988, Genetics.

[62]  T. Devereux,et al.  Mutations in ras genes in experimental tumours of rodents. , 1999, IARC scientific publications.

[63]  Richard E. Wilson,et al.  Low‐dose linearity: The rule or the exception? , 1996 .

[64]  J. Huff,et al.  Frequent p53 and H-ras Mutations in Benzene- and Ethylene Oxide-Induced Mammary Gland Carcinomas from B6C3F1 Mice , 2006, Toxicologic pathology.

[65]  N. Mantel,et al.  "Safety" testing of carcinogenic agents. , 1961, Journal of the National Cancer Institute.

[66]  P. Lord,et al.  Proto-oncogene activation in liver tumors of hepatocarcinogenesis-resistant strains of mice. , 1992, Carcinogenesis.

[67]  M. You,et al.  Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. , 1993, Carcinogenesis.

[68]  I C Munro,et al.  Risk assessment and regulatory decision making. , 1981, Food and cosmetics toxicology.

[69]  C. Bloomfield,et al.  ras oncogene activation and occupational exposures in acute myeloid leukemia. , 1992, Journal of the National Cancer Institute.

[70]  I. Linkov,et al.  The effect of different tumor groupings on findings of anticarcinogenic responses in long-term rodent bioassays. , 2002, Regulatory toxicology and pharmacology : RTP.

[71]  D G Hoel,et al.  Estimation of risks of irreversible, delayed toxicity. , 1975, Journal of toxicology and environmental health.

[72]  G. Childs,et al.  Comparison of chemically induced and spontaneous murine thymic lymphomas in RF and AKR mice: differential expression of c-myc and c-myb. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Li Ding,et al.  Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.

[74]  S. Peddada,et al.  Hepatocellular Carcinomas in B6C3F1 Mice Treated with Ginkgo biloba Extract for Two Years Differ from Spontaneous Liver Tumors in Cancer Gene Mutations and Genomic Pathways , 2013, Toxicologic pathology.

[75]  A. Knudson.  Heredity and human cancer. , 1974, The American journal of pathology.

[76]  R. Platt.  CLONAL AGEING AND CANCER , 1955 .

[77]  S. Nesnow,et al.  Benzo[b]fluoranthene: tumorigenicity in strain A/J mouse lungs, DNA adducts and mutations in the Ki-ras oncogene. , 1996, Carcinogenesis.

[78]  Y. Takeshima,et al.  Effects of K‐ras Gene Mutations in the Development of Lung Lesions Induced by 4‐(N‐ Methyl‐N‐nitrosamino)‐1‐(3‐pyridyl)‐1‐butanone in A/J Mice , 1996, Japanese journal of cancer research : Gann.

[79]  J. Miller,et al.  Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[80]  E. Calabrese.  Post-conditioning hormesis creates a “subtraction to background” disease process: biological, aging, and environmental risk assessment implications , 2018, Journal of Cell Communication and Signaling.

[81]  H. Muller.  Radiation damage to the genetic material. , 1950, American scientist.

[82]  Edward J Calabrese,et al.  Hormesis: the dose-response revolution. , 2003, Annual review of pharmacology and toxicology.

[83]  F. Sotgia,et al.  Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment , 2013, Cell cycle.

[84]  Ronald H. White,et al.  State-of-the-Science Workshop Report: Issues and Approaches in Low-Dose–Response Extrapolation for Environmental Health Risk Assessment , 2008, Environmental health perspectives.

[85]  R. Maronpot,et al.  H-ras oncogene mutation spectra in B6C3F1 and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells. , 1995, Carcinogenesis.

[86]  Nordling Co.  A New Theory on the Cancer-inducing Mechanism , 1953 .

[87]  H. Ananthaswamy,et al.  Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines , 2004, Oncogene.

[88]  E A Crouch,et al.  Dose-response relationships for carcinogens: a review. , 1987, Environmental health perspectives.

[89]  F. Staedtler,et al.  Differentiation of spontaneous and induced mammary adenocarcinomas of the rat by gene expression profiling. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[90]  M. Schneiderman,et al.  Estimating cancer risks to a population. , 1978, Environmental health perspectives.

[91]  J. Cornfield,et al.  Carcinogenic risk assessment. , 1977, Science.

[92]  D. Crawford‐Brown,et al.  Explanation of protective effects of low doses of γ -radiation with a mechanistic radiobiological model , 2002, International journal of radiation biology.

[93]  P. Armitage,et al.  The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.

[94]  L. DiPietro.  A Silent Spring? , 2017, Journal of physical activity & health.

[95]  R. Wilson.  Risk caused by low levels of pollution. , 1978 .

[96]  I. Szadkowska-stanczyk,et al.  Cancer risk assessment: present and future. , 2005, International journal of occupational medicine and environmental health.

[97]  R. Albert,et al.  Considerations relating to the formulation of limits for unavoidable population exposures to environmental carcinogens , 1972 .

[98]  P. McKinzie,et al.  Accumulation of K‐Ras codon 12 mutations in the F344 rat distal colon following azoxymethane exposure , 2011, Environmental and molecular mutagenesis.

[99]  S. Peddada,et al.  Gene Expression of Mesothelioma in Vinylidene Chloride–exposed F344/N Rats Reveal Immune Dysfunction, Tissue Damage, and Inflammation Pathways , 2015, Toxicologic pathology.

[100]  D P Lovell.  Dose-response and threshold-mediated mechanisms in mutagenesis: statistical models and study design. , 2000, Mutation research.

[101]  W. W. Nichols,et al.  Activation of the Ki‐ras gene in spontaneous and chemically induced lung tumors in CD‐1 mice , 1992, Molecular carcinogenesis.

[102]  Peter Reading,et al.  High-throughput deep sequencing reveals that microRNAs play important roles in salt tolerance of euhalophyte Salicornia europaea , 2015, BMC Plant Biology.

[103]  An elementary theory leading to non-linear dose-risk relationships for radiation carcinogenesis. , 1969, British Journal of Cancer.

[104]  M. Shimkin,et al.  Quantitative Analysis of Dose-Response Data Obtained With Three Carcinogenic Hydrocarbons in Strain C3H Male Mice , 1943 .

[105]  H J Muller,et al.  ARTIFICIAL TRANSMUTATION OF THE GENE. , 1927, Science.

[106]  D. Hoel.  Incorporation of background in dose-response models. , 1980, Federation proceedings.

[107]  C. Martins,et al.  Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities , 2016, Nature.

[108]  P. Armitage,et al.  The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.

[109]  P. Ricci,et al.  Ionizing radiations epidemiology does not support the LNT model. , 2019, Chemico-biological interactions.

[110]  A. Kopp-Schneider,et al.  J-Shaped Dose-Response Relationship for Tumor Induction by Caffeic Acid in the Rat Forestomach, Modeled by Non-Monotonic Dose Response for DNA Damage and Cell Proliferation , 2001 .

[111]  J. Redpath,et al.  The Shape of the Dose–Response Curve for Radiation-Induced Neoplastic Transformation In Vitro: Evidence for an Adaptive Response against Neoplastic Transformation at Low Doses of Low-LET Radiation , 2001, Radiation research.

[112]  J. Goodman,et al.  Alterations in the methylation status and expression of the raf oncogene in phenobarbital‐induced and spontaneous B6C3F1 mouse liver tumors , 1994, Molecular carcinogenesis.

[113]  J. H. Hollomon,et al.  A hypothesis for the origin of cancer foci , 1951, Cancer.

[114]  J. Subramanian,et al.  Molecular profile of lung cancer in never smokers , 2013, EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.].

[115]  B. Allen,et al.  Dose and temporal evaluation of ethylene oxide‐induced mutagenicity in the lungs of male big blue mice following inhalation exposure to carcinogenic concentrations , 2017, Environmental and molecular mutagenesis.

[116]  R. Maronpot,et al.  Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. , 1995, Toxicology.

[117]  J. Abel,et al.  Distinct spectrum of mutations induced by crocidolite asbestos: clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo. , 2002, Cancer research.

[118]  R. Peto.  Carcinogenic effects of chronic exposure to very low levels of toxic substances. , 1978, Environmental health perspectives.

[119]  Edward J. Calabrese,et al.  Hormesis: Why it is important to toxicology and toxicologists , 2008 .

[120]  R. Maronpot,et al.  Oncogene activation in spontaneous and chemically induced rodent tumors: implications for risk analysis. , 1988, Environmental health perspectives.

[121]  J. Tukey,et al.  An improved Mantel-Bryan procedure for "safety" testing of carcinogens. , 1975, Cancer research.

[122]  Scientific bases for identification of potential carcinogens and estimation of risks. Interagency Regulatory Liaison Group, Work Group on Risk Assessment. , 1980, Annual review of public health.

[123]  J. Redpath,et al.  Low-Dose Reduction in Transformation Frequency Compared to Unirradiated Controls: The Role of Hyper-radiosensitivity to Cell Death , 2003, Radiation research.

[124]  E. Calabrese.  Preconditioning is hormesis part I: Documentation, dose-response features and mechanistic foundations. , 2016, Pharmacological Research.

[125]  A. Knudson.  Mutation and Human Cancer , 1973 .

[126]  P. Stocks.  A Study of the Age Curve for Cancer of the Stomach in Connection with a Theory of the Cancer Producing Mechanism , 1953, British Journal of Cancer.

[127]  E. Calabrese.  Preconditioning is hormesis part II: How the conditioning dose mediates protection: Dose optimization within temporal and mechanistic frameworks. , 2016, Pharmacological research.

[128]  S. Peddada,et al.  Spontaneous Mesotheliomas in F344/N Rats Are Characterized by Dysregulation of Cellular Growth and Immune Function Pathways , 2014, Toxicologic pathology.

[129]  John Gardenier.  Quantitative risk assessment , 1988 .

[130]  R. Sills,et al.  K-ras Mutations in Lung Tumors and Tumors from Other Organs are Consistent with a Common Mechanism of Ethylene Oxide Tumorigenesis in the B6C3F1 Mouse , 2007, Toxicologic pathology.

[131]  D. Gaylor.  Relationship between the shape of dose-response curves and background tumor rates. , 1992, Regulatory toxicology and pharmacology : RTP.

[132]  S. Toledo,et al.  Low-dose ionizing radiation decreases the frequency of neoplastic transformation to a level below the spontaneous rate in C3H 10T1/2 cells. , 1996, Radiation research.

[133]  Z. Ronai,et al.  G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. , 1993, Carcinogenesis.

[134]  F. Meng,et al.  Oncomutations as biomarkers of cancer risk , 2010, Environmental and molecular mutagenesis.

[135]  R. Albert,et al.  Carcinogen risk assessment in the U.S. Environmental Protection Agency. , 1994, Critical reviews in toxicology.

[136]  W. Stahel,et al.  Statistical procedures to test for linearity and estimate threshold doses for tumor induction with nonlinear dose-response relationships in bioassays for carcinogenicity. , 2002, Regulatory toxicology and pharmacology : RTP.

[137]  S. Molloi,et al.  Low doses of diagnostic energy X-rays protect against neoplastic transformation in vitro , 2003, International journal of radiation biology.

[138]  R. Melnick,et al.  Point mutations of K-ras and H-ras genes in forestomach neoplasms from control B6C3F1 mice and following exposure to 1,3-butadiene, isoprene or chloroprene for up to 2-years. , 2001, Chemico-biological interactions.

[139]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[140]  R. Maronpot,et al.  Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[141]  H. Blum,et al.  Relationships Between Dosage and Rate of Tumor Induction by Ultraviolet Radiation , 1942 .

[142]  P. Söderkvist,et al.  Frequent mutations of the Trp53, Hras1 and β-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice , 2002, Oncogene.

[143]  S. Moolgavkar,et al.  Chapter 6: Lung Cancer in Never Smokers: Epidemiology and Risk Prediction Models , 2012, Risk analysis : an official publication of the Society for Risk Analysis.

[144]  R R Maronpot,et al.  Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. , 1987, Science.

[145]  C. Stern,et al.  Experiments to Test the Validity of the Linear R-Dose/Mutation Frequency Relation in Drosophila at Low Dosage. , 1948, Genetics.

[146]  J. Crow,et al.  Anecdotal, Historical and Critical Commentaries on Genetics , 1994 .

[147]  N. Arley,et al.  ON THE MECHANISM OF EXPERIMENTAL CARCINOGENESIS , 2009 .

[148]  Toshiaki Okada,et al.  Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice. , 2007, Lung cancer.

[149]  Marshall W. Anderson,et al.  Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[150]  Richard Wilson,et al.  The Development of Risk Analysis: A Personal Perspective , 2012, Risk analysis : an official publication of the Society for Risk Analysis.

[151]  José Cortiñas Abrahantes,et al.  Update: use of the benchmark dose approach in risk assessment , 2017, EFSA journal. European Food Safety Authority.

[152]  D. Uphoff,et al.  The Genetic Effects of Low Intensity Irradiation. , 1948, Science.

[153]  R. Kodell.  U-Shaped Dose-Response Relationships for Mutation and Cancer , 2001 .

[154]  Bogen's Critique of Linear‐No‐Threshold Default Assumptions , 2017, Risk analysis : an official publication of the Society for Risk Analysis.

[155]  N. Barrass,et al.  Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone. , 1991, Carcinogenesis.

[156]  R. Mittelstaedt,et al.  Sequence specificity of Hprt lymphocyte mutation in rats fed the hepatocarcinogen 2-acetylaminofluorene. , 1999, Mutation research.

[157]  H. Jones,et al.  Environmental factors in the origin of cancer and estimation of the possible hazard to man. , 1975, Food and cosmetics toxicology.

[158]  R. Maronpot,et al.  Activation of K-ras in aflatoxin B1-induced lung tumors from AC3F1 (A/J x C3H/HeJ) mice. , 1996, Carcinogenesis.